News
AN2 Therapeutics completes dosing first single ascending dose cohort in phase 1 first-in-human clinical trial of oral AN2-502998 for Chagas disease: Menlo Park, California Thursda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback